Royal Bank Of Canada United Therapeutics Corp Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

A detailed history of Royal Bank Of Canada transactions in United Therapeutics Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 35,588 shares of UTHR stock, worth $12.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,588
Previous 34,829 2.18%
Holding current value
$12.6 Million
Previous $11.1 Million 14.95%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$311.04 - $363.55 $236,079 - $275,934
759 Added 2.18%
35,588 $12.8 Million
Q2 2024

Nov 06, 2024
SELL
$228.26 - $319.04 $3.2 Million - $4.47 Million
-14,000 Reduced 28.67%
34,829 $11.1 Million
Q2 2024

Aug 14, 2024
BUY
$228.26 - $319.04 $1.25 Million - $1.75 Million
5,470 Added 12.62%
48,829 $15.6 Million
Q1 2024

Nov 05, 2024
SELL
$210.76 - $249.51 $1.78 Million - $2.11 Million
-8,443 Reduced 17.29%
40,386 $9.28 Million
Q1 2024

May 15, 2024
BUY
$210.76 - $249.51 $2.52 Million - $2.98 Million
11,936 Added 37.98%
43,359 $9.96 Million
Q4 2023

Feb 14, 2024
BUY
$214.88 - $256.94 $3.84 Million - $4.59 Million
17,881 Added 132.04%
31,423 $6.91 Million
Q3 2023

Nov 14, 2023
BUY
$211.82 - $248.24 $596,273 - $698,795
2,815 Added 26.24%
13,542 $3.06 Million
Q2 2023

Aug 14, 2023
BUY
$205.19 - $232.99 $310,862 - $352,979
1,515 Added 16.45%
10,727 $2.37 Million
Q1 2023

May 15, 2023
SELL
$212.99 - $276.17 $1.4 Million - $1.82 Million
-6,578 Reduced 41.66%
9,212 $2.06 Million
Q4 2022

Feb 14, 2023
SELL
$205.95 - $280.43 $1.41 Million - $1.92 Million
-6,859 Reduced 30.28%
15,790 $4.39 Million
Q3 2022

Nov 14, 2022
BUY
$203.3 - $244.17 $343,577 - $412,647
1,690 Added 8.06%
22,649 $4.74 Million
Q2 2022

Aug 15, 2022
SELL
$174.81 - $241.14 $397,692 - $548,593
-2,275 Reduced 9.79%
20,959 $4.94 Million
Q1 2022

May 16, 2022
SELL
$166.16 - $213.96 $2.18 Million - $2.8 Million
-13,097 Reduced 36.05%
23,234 $4.17 Million
Q4 2021

Feb 14, 2022
BUY
$184.32 - $216.08 $1.83 Million - $2.14 Million
9,910 Added 37.51%
36,331 $7.85 Million
Q3 2021

Nov 15, 2021
BUY
$179.86 - $214.88 $589,760 - $704,591
3,279 Added 14.17%
26,421 $4.88 Million
Q2 2021

Aug 16, 2021
BUY
$170.47 - $211.93 $3.95 Million - $4.9 Million
23,142 New
23,142 $4.15 Million

Others Institutions Holding UTHR

# of Institutions
673
Shares Held
42.2M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email